![WO2006127898A2 - (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use - Google Patents WO2006127898A2 - (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use - Google Patents](https://patentimages.storage.googleapis.com/bb/69/47/1650beb7db7840/imgf000067_0001.png)
WO2006127898A2 - (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use - Google Patents
![Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent | Journal of Medicinal Chemistry Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b01187/asset/images/medium/jm-2018-01187z_0022.gif)
Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent | Journal of Medicinal Chemistry
![EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents](https://patentimages.storage.googleapis.com/25/b1/f5/73699bfaed3999/imgb0041.png)
EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents
![DNA topoisomerase 2-associated proteins PATL1 and PATL2 regulate the biogenesis of hERG K+ channels | PNAS DNA topoisomerase 2-associated proteins PATL1 and PATL2 regulate the biogenesis of hERG K+ channels | PNAS](https://www.pnas.org/cms/10.1073/pnas.2206146120/asset/8f45439d-a9da-4d86-accd-215c8dd3c4fc/assets/images/large/pnas.2206146120fig01.jpg)
DNA topoisomerase 2-associated proteins PATL1 and PATL2 regulate the biogenesis of hERG K+ channels | PNAS
![WO2006127898A2 - (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use - Google Patents WO2006127898A2 - (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use - Google Patents](https://patentimages.storage.googleapis.com/b9/ae/56/e2c574963ff49e/imgf000013_0001.png)
WO2006127898A2 - (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use - Google Patents
General procedure for the synthesis of mono-N-acylated 1,6-diaminohexanes | The Journal of Organic Chemistry
![IJMS | Free Full-Text | Main Applications of Cyclodextrins in the Food Industry as the Compounds of Choice to Form Host–Guest Complexes IJMS | Free Full-Text | Main Applications of Cyclodextrins in the Food Industry as the Compounds of Choice to Form Host–Guest Complexes](https://pub.mdpi-res.com/ijms/ijms-22-01339/article_deploy/html/images/ijms-22-01339-ag.png?1612248789)
IJMS | Free Full-Text | Main Applications of Cyclodextrins in the Food Industry as the Compounds of Choice to Form Host–Guest Complexes
![Pharmaceuticals | Free Full-Text | Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design Pharmaceuticals | Free Full-Text | Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01062/article_deploy/html/images/pharmaceuticals-14-01062-g001.png)
Pharmaceuticals | Free Full-Text | Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design
![IJMS | Free Full-Text | Main Applications of Cyclodextrins in the Food Industry as the Compounds of Choice to Form Host–Guest Complexes IJMS | Free Full-Text | Main Applications of Cyclodextrins in the Food Industry as the Compounds of Choice to Form Host–Guest Complexes](https://pub.mdpi-res.com/ijms/ijms-22-01339/article_deploy/html/images/ijms-22-01339-g001.png?1612248707)
IJMS | Free Full-Text | Main Applications of Cyclodextrins in the Food Industry as the Compounds of Choice to Form Host–Guest Complexes
![EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents](https://patentimages.storage.googleapis.com/30/37/18/50f8eb601b4e13/imgb0011.png)
EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents
![EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents](https://patentimages.storage.googleapis.com/ef/a4/cc/cb2b8cac4be35b/imgb0007.png)
EP2792360A1 - (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV - Google Patents
![WO2020212952A1 - Treatment of depression and other various disorders with psilocybin - Google Patents WO2020212952A1 - Treatment of depression and other various disorders with psilocybin - Google Patents](https://patentimages.storage.googleapis.com/7e/15/e6/ea1bf15233b0f9/imgf000184_0002.png)